Literature DB >> 16572860

QTc interval prolongation predicts postoperative mortality in heart failure patients undergoing surgical revascularization.

Bojan Vrtovec1, Aria P Ryazdanbakhsh, Tatjana Pintar, Charles D Collard, Igor D Gregoric, Branislav Radovancevic.   

Abstract

QTc interval prolongation is associated with increased mortality rates in patients with advanced heart failure. We investigated the predictive value of prolonged QTc interval in 567 patients with heart failure who were undergoing coronary artery bypass graft surgery The patients were in New York Heart Association class III or IV, with left ventricular ejection fractions of 0.40 or less. Before surgery, the QT interval duration was measured in leads II and V4 of the standard electrocardiogram and corrected by use of the Bazett formula. The QTc interval was prolonged (>440 msec) in 243 patients (43%) and normal in 324 (57%). The 2 study groups--prolonged QTc versus normal QTc--did not differ in terms of age (62 +/- 11 years vs 64 +/- 10 years, P=0.65), sex (80% male vs 76% male, P=0.31), ejection fraction (0.29 +/- 0.08 vs 0.29 +/- 0.09, P=0.72), hypertension (82% vs 78%, P=0.34), or diabetes (11% vs 7%, P=0.10). Within 1 month after coronary artery bypass grafting, 22 of 243 patients (9.1%) in the prolonged QTc group died, compared with 5 of 324 in the normal QTc group (1.5%) (P=0.0001). QTc interval prolongation was the only independent predictor of postoperative mortality on multivariate analysis (P=0.002). We conclude that patients with heart failure and preoperative QTc interval prolongation have increased mortality rates after coronary artery bypass grafting.

Entities:  

Mesh:

Year:  2006        PMID: 16572860      PMCID: PMC1413604     

Source DB:  PubMed          Journal:  Tex Heart Inst J        ISSN: 0730-2347


  23 in total

1.  Risk factors for intermediate-term survival after coronary artery bypass grafting.

Authors:  S C Gardner; G K Grunwald; J S Rumsfeld; T Mackenzie; D Gao; J B Perlin; G McDonald; A L Shroyer
Journal:  Ann Thorac Surg       Date:  2001-12       Impact factor: 4.330

2.  More light on QT interval measurement.

Authors:  L Toivonen
Journal:  Heart       Date:  2002-03       Impact factor: 5.994

3.  Long-term trends in the incidence of and survival with heart failure.

Authors:  Daniel Levy; Satish Kenchaiah; Martin G Larson; Emelia J Benjamin; Michelle J Kupka; Kalon K L Ho; Joanne M Murabito; Ramachandran S Vasan
Journal:  N Engl J Med       Date:  2002-10-31       Impact factor: 91.245

4.  Qtc interval as a guide to select those patients with congestive heart failure and reduced left ventricular systolic function who will benefit from antiarrhythmic treatment with dofetilide.

Authors:  B Brendorp; H Elming; L Jun; L Køber; M Malik; G B Jensen; C Torp-Pedersen
Journal:  Circulation       Date:  2001-03-13       Impact factor: 29.690

5.  QT interval duration in 24-hour Holter monitoring after different interventional treatment of coronary artery disease in patients after the myocardial infarction.

Authors:  J K Wranicz; J Ruta; M Strzondała; M Kośmider; H Bolińska; J Zasłonka
Journal:  Med Sci Monit       Date:  2000 Jan-Feb

6.  Autonomic nervous system influences on QT interval in normal subjects.

Authors:  Anthony R Magnano; Steve Holleran; Rajasekhar Ramakrishnan; James A Reiffel; Daniel M Bloomfield
Journal:  J Am Coll Cardiol       Date:  2002-06-05       Impact factor: 24.094

Review 7.  Heart failure and neuroendocrine activation: diagnostic, prognostic and therapeutic perspectives.

Authors:  A Kjaer; B Hesse
Journal:  Clin Physiol       Date:  2001-11

Review 8.  Cellular mechanisms underlying the long QT syndrome.

Authors:  Charles Antzelevitch; Wataru Shimizu
Journal:  Curr Opin Cardiol       Date:  2002-01       Impact factor: 2.161

9.  Prolonged QTc interval and high B-type natriuretic peptide levels together predict mortality in patients with advanced heart failure.

Authors:  Bojan Vrtovec; Reynolds Delgado; Aly Zewail; Cynthia D Thomas; Barbara M Richartz; Branislav Radovancevic
Journal:  Circulation       Date:  2003-03-24       Impact factor: 29.690

Review 10.  QTc interval in the assessment of cardiac risk.

Authors:  Hanne Elming; Bente Brendorp; Lars Køber; Najia Sahebzadah; Christian Torp-Petersen
Journal:  Card Electrophysiol Rev       Date:  2002-09
View more
  5 in total

1.  Application of the Bogossian formula for evaluation of the QT interval in pacemaker patients with stimulated left bundle branch block.

Authors:  K F Weipert; H Bogossian; P Conzen; G Frommeyer; C Gemein; I Helmig; R Chasan; L Eckardt; M Seyfarth; B Lemke; M Zarse; C W Hamm; J Schmitt; D Erkapic
Journal:  Clin Res Cardiol       Date:  2018-05-11       Impact factor: 5.460

2.  QTc Prolongation after Ventricular Septal Defect Repair in Infants.

Authors:  Chang Woo Han; Saet Byul Woo; Jae Young Choi; Jo Won Jung; Yong Hwan Park; Han Ki Park; Hong Ju Shin; Nam Kyun Kim
Journal:  Korean Circ J       Date:  2013-12-20       Impact factor: 3.243

3.  Interleukin-1β gene variants are associated with QTc interval prolongation following cardiac surgery: a prospective observational study.

Authors:  Miklos D Kertai; Yunqi Ji; Yi-Ju Li; Joseph P Mathew; James P Daubert; Mihai V Podgoreanu
Journal:  Can J Anaesth       Date:  2016-02-08       Impact factor: 5.063

4.  LQTS mutation N1325S in cardiac sodium channel gene SCN5A causes cardiomyocyte apoptosis, cardiac fibrosis and contractile dysfunction in mice.

Authors:  Teng Zhang; Sandro L Yong; Jeanne K Drinko; Zoran B Popović; John C Shryock; Luiz Belardinelli; Qing Kenneth Wang
Journal:  Int J Cardiol       Date:  2009-09-17       Impact factor: 4.164

5.  Bisoprolol reverses down-regulation of potassium channel proteins in ventricular tissues of rabbits with heart failure.

Authors:  Xi Li; Tingzhong Wang; Ke Han; Xiaozhen Zhuo; Qun Lu; Aiqun Ma
Journal:  J Biomed Res       Date:  2011-07
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.